Join us for a three-part webinar series: An Introduction to Digital Health for the Patient Community
Digital medicine is broadly defined as “a field, concerned with the use of technologies as tools for measurement and intervention in the service of human health.” Digital health tools span an exceptionally wide range of uses including general wellness apps, precision diagnostics, telemedicine, and medical devices.
During this three-part series, our guest speakers will introduce attendees to key topics related to digital health. In the first webinar, you will learn about key terminology and the current regulatory and reimbursement landscape. During the second webinar, you will hear about two examples of patient community engagement in development of mobile apps. In the third webinar, we will discuss barriers and facilitators to providing care to vulnerable communities and the lessons learned after 18 months of telehealth uptake during the COVID pandemic. This webinar series is ideal for members of the patient advocate and health care community who are interested in engaging in conversations about digital health.
mHealth, Digital Health, Digital Therapeutics: Terminology & Current Landscape
February 11, 12:00 p.m. – 12:45 p.m. ET
- Ieuan Clay, PhD, MSci, Chief Scientific Officer, Digital Medicine Society
- Megan Coder, PharmD, MBA, Chief Policy Officer, Digital Therapeutics Alliance
mHealth & Examples of Patient Community Engagement
February 18, 12:00pm-12:45 p.m. ET
- Wendy Camelo Castillo, PhD, Assistant Professor, University of Maryland School of Pharmacy
- Angela Dobes, MPH, Senior Director, IBD Plexus, Crohn’s & Colitis Foundation
Digital Health & Health Equity
February 25, 12:00pm-12:45 p.m. ET
- Beverly Butler, SWATS LLC, PAVE Center Stakeholder Advisor
- Juan Caicedo, Executive Director, Heritage Care, Inc., PAVE Center Stakeholder Advisor
- Jennifer Dexter, Director of Policy, National Health Council
This webinar series was organized by the PAVE Center, a collaboration between the National Health Council and the University of Maryland. The PAVE Center is supported by the PhRMA Foundation.
AMCP 2021 Partnership Forum “The Evolving Role of Digital Therapeutics”
This forum identified challenges and payer needs related to the evidence for digital therapeutics. The forum explored the current market space for digital therapeutics including the evidence for the products, place in therapy, monitoring or utilization metrics and barriers that patients face in obtaining therapies. Read more here.
AMCP 2019 Partnership Forum “Digital Therapeutics: What Are They and Where Do They Fit in Pharmacy and Medical Benefits?”
In this forum participants discussed how digital therapeutics with web and designed based applications are emerging as a means to treat conditions by engaging people to improve health and wellness; participants also provided recommendations to inform this growing area. Read more here.